These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Association between duration of digoxin use and adverse outcomes among Chinese patients with atrial fibrillation]. Chang SS, Gao Y, Xia SJ, Du X, Dong JZ, Ma CS. Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep 24; 48(9):728-734. PubMed ID: 32957754 [Abstract] [Full Text] [Related]
3. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Washam JB, Stevens SR, Lokhnygina Y, Halperin JL, Breithardt G, Singer DE, Mahaffey KW, Hankey GJ, Berkowitz SD, Nessel CC, Fox KA, Califf RM, Piccini JP, Patel MR, ROCKET AF Steering Committee and Investigators. Lancet; 2015 Jun 13; 385(9985):2363-70. PubMed ID: 25749644 [Abstract] [Full Text] [Related]
4. Predictors of digoxin use and risk of mortality in ED patients with atrial fibrillation. Wu S, Yang YM, Zhu J, Ren JM, Wang J, Zhang H, Shao XH. Am J Emerg Med; 2017 Nov 13; 35(11):1589-1594. PubMed ID: 28551087 [Abstract] [Full Text] [Related]
6. Digoxin and risk of death in adults with atrial fibrillation: the ATRIA-CVRN study. Freeman JV, Reynolds K, Fang M, Udaltsova N, Steimle A, Pomernacki NK, Borowsky LH, Harrison TN, Singer DE, Go AS. Circ Arrhythm Electrophysiol; 2015 Feb 13; 8(1):49-58. PubMed ID: 25414270 [Abstract] [Full Text] [Related]
7. Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study. Dong Z, Du X, Lu S, Jiang C, Xia S, He L, Su X, Jia Z, Long D, Sang C, Tang R, Liu N, Bai R, Yu R, Dong J, Ma C. BMC Cardiovasc Disord; 2021 Mar 19; 21(1):146. PubMed ID: 33740910 [Abstract] [Full Text] [Related]
8. Interaction between digoxin and dronedarone in the PALLAS trial. Hohnloser SH, Halperin JL, Camm AJ, Gao P, Radzik D, Connolly SJ, PALLAS investigators. Circ Arrhythm Electrophysiol; 2014 Dec 19; 7(6):1019-25. PubMed ID: 25378467 [Abstract] [Full Text] [Related]
19. Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: insights from the Atrial Fibrillation and Congestive Heart Failure Trial. Frasure-Smith N, Lespérance F, Talajic M, Khairy P, Dorian P, O'Meara E, Roy D. Circ Heart Fail; 2012 May 01; 5(3):322-30. PubMed ID: 22441774 [Abstract] [Full Text] [Related]